comparemela.com
Home
Live Updates
Bergenbio First Quarter Results 2024: Advancing To The Next Stage Of Development : comparemela.com
Bergenbio First Quarter Results 2024: Advancing To The Next Stage Of Development
BERGEN, Norway, May 29, 2024 /PRNewswire/ -- BerGenBio ASA (OSE: BGBIO), a clinical-stage bio-pharmaceutical company developing novel, selective AXL
Related Keywords
Texas ,
United States ,
Oslo ,
Norway ,
Lilleby ,
Øtfold ,
United Kingdom ,
Norwegian ,
Prnewswire Bergenbio ,
Martin Olin ,
Mays Cancer Center ,
Oslo Stock Exchange ,
National Cancer Institute ,
Safety Monitoring Board ,
Texas Health Science Center ,
San Antonio ,
Chief Executive Officer ,
Financial Report ,
Financial Reports ,
Abuse Regulation ,
Norwegian Securities Trading ,
comparemela.com © 2020. All Rights Reserved.